US Senior Medical Director, Rare Hematology
Sanofi
July 02, 2026
Remote friendly (Cambridge, MA)
United States
$206,250 - $343,750 USD yearly
Medical Affairs
Main Responsibilities
- Develop U.S. medical objectives and strategies across the rare hematology portfolio aligned with U.S. commercial goals.
- Provide medical input to brand teams on strategy, tactics, and development of claims.
- Serve as internal expert for rare hematologic conditions/products and support field-based U.S. Medical Affairs.
- Develop strategies for and implement medical advisory boards.
- Lead execution of the strategic U.S. investigator-sponsored study program.
- Develop U.S. scientific communication and publication strategies.
- Partner with R&D to support clinical trials across the rare hematology portfolio.
- Lead medical affairs activities for the near-term launch of rilzabrutinib (rilza) for ITP.
- Engage and present to cross-functional leadership/governance forums to advance therapeutic area strategy.
- Drive preparation for future lifecycle management and upcoming product launches.
- Provide strategic direction to disease-specific MSL teams; support product/disease-state training.
- Support Managed Markets discussions with payers; review Educational Outreach Grants.
- Ensure ethical, credible promotion and compliance with corporate/industry/legal/regulatory requirements; potentially sit on Promotional and Medical Review boards.
- Maintain medical/scientific knowledge via continuing education; attend symposia; track current literature.
- Stay updated on emerging scientific/technological/regulatory developments.
- Approximately 20% travel expected.
Qualifications
Basic Qualifications:
- Doctorate degree (PhD or PharmD). MD considered with relevant experience.
- 10+ years of Medical Affairs experience with strategic and tactical planning/execution.
- Experience in rare hematology or related therapeutic area (ITP, wAIHA, SCD, or adjacent rare blood disorders).
Preferred Qualifications:
- Strategic thinker/planner.
- Strong oral/written communication and presentation skills.
- Excellent interpersonal skills; build relationships; manage/resolve conflict.
- Highly organized; effective in matrixed, cross-functional environment; team-oriented.
- Experience developing, conducting, and publishing peer-reviewed scientific/clinical research.
- Additional training/experience in epidemiology, health economics, health policy, and outcomes-based research/practice.
- Passion for improving outcomes for patients with rare hematologic conditions.
- Commitment to highest ethical, legal, regulatory, and scientific standards.
- Develop U.S. medical objectives and strategies across the rare hematology portfolio aligned with U.S. commercial goals.
- Provide medical input to brand teams on strategy, tactics, and development of claims.
- Serve as internal expert for rare hematologic conditions/products and support field-based U.S. Medical Affairs.
- Develop strategies for and implement medical advisory boards.
- Lead execution of the strategic U.S. investigator-sponsored study program.
- Develop U.S. scientific communication and publication strategies.
- Partner with R&D to support clinical trials across the rare hematology portfolio.
- Lead medical affairs activities for the near-term launch of rilzabrutinib (rilza) for ITP.
- Engage and present to cross-functional leadership/governance forums to advance therapeutic area strategy.
- Drive preparation for future lifecycle management and upcoming product launches.
- Provide strategic direction to disease-specific MSL teams; support product/disease-state training.
- Support Managed Markets discussions with payers; review Educational Outreach Grants.
- Ensure ethical, credible promotion and compliance with corporate/industry/legal/regulatory requirements; potentially sit on Promotional and Medical Review boards.
- Maintain medical/scientific knowledge via continuing education; attend symposia; track current literature.
- Stay updated on emerging scientific/technological/regulatory developments.
- Approximately 20% travel expected.
Qualifications
Basic Qualifications:
- Doctorate degree (PhD or PharmD). MD considered with relevant experience.
- 10+ years of Medical Affairs experience with strategic and tactical planning/execution.
- Experience in rare hematology or related therapeutic area (ITP, wAIHA, SCD, or adjacent rare blood disorders).
Preferred Qualifications:
- Strategic thinker/planner.
- Strong oral/written communication and presentation skills.
- Excellent interpersonal skills; build relationships; manage/resolve conflict.
- Highly organized; effective in matrixed, cross-functional environment; team-oriented.
- Experience developing, conducting, and publishing peer-reviewed scientific/clinical research.
- Additional training/experience in epidemiology, health economics, health policy, and outcomes-based research/practice.
- Passion for improving outcomes for patients with rare hematologic conditions.
- Commitment to highest ethical, legal, regulatory, and scientific standards.